Reminder to Agilon Health Investors of Securities Class Action Lawsuit by Faruqi & Faruqi, LLP

Agilon Health investors have been reminded by Faruqi & Faruqi LLP of the approaching deadline for a securities class action lawsuit. The deadline, set for March 2, 2026, urges investors to take action if they suffered losses during a specific time frame related to the company’s securities transactions. Faruqi & Faruqi LLP, a prominent national securities law firm, is actively investigating potential claims against agilon health, inc. Such claims suggest that the company and its executives were involved in violations of federal securities laws due to false or misleading statements and omissions.

The allegations against the company involve claims that the defendants irresponsibly provided guidance for the year 2025, which was unattainable due to known industry challenges. Additionally, it is believed that the positive financial outcomes stemming from agilon’s strategic actions to minimize risks were exaggerated. These misrepresentations allegedly led to false and misleading statements about agilon’s overall business, operations, and future prospects. When the genuine information was revealed to the market, investors allegedly suffered financial losses as a result.

One crucial incident that impacted agilon health’s stock significantly was the press release issued on August 4, 2025. In this release, agilon health announced its second-quarter results for 2025. The Executive Chair highlighted the challenging realities, stating that industry challenges were more severe than initially anticipated, leading to the suspension of previously issued financial guidance for the full year 2025. Consequently, agilon’s stock experienced a notable drop of 51.5% on August 5, 2025, following this announcement.

Investors have the opportunity to take legal action and potentially become the lead plaintiff in the securities class action lawsuit against agilon health. The lead plaintiff is typically an investor with the most substantial financial stake in the class’s sought relief, representing the interests of other class members in the litigation process. Nonetheless, any eligible class member can opt to serve as the lead plaintiff or remain passive, with their recovery prospects unaffected by this decision.

Faruqi & Faruqi LLP encourages individuals with relevant information regarding agilon health’s conduct to come forward, including whistleblowers, former employees, and shareholders. To gain additional insights into the agilon health class action case, interested parties can reach out directly to Faruqi & Faruqi partners for more information. The law firm’s commitment to ensuring confidentiality underscores its dedication to every case handled.